Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Wasatch Advisors is an investment management company specializing in equity funds. The company manages institutional and individual portfolios. The company was formed in 1975 by Sam Stewart and still follows his philosophy of a bottom-up research method that focuses on long-term growth and finding market inefficiencies. Wasatch Advisors maintains its headquarters at Salt Lake City, Utah.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2014 | DataStax | Series E | 106M |
7/2003 | BlueArc | Series D | 47M |
11/2006 | Orexigen Therapeutics, Inc. | Series C | 30M |
5/2015 | DocuSign | Series F | 0 |
7/2000 | Metro Optix | Series B | 63M |
7/2005 | TherOx | Venture Round | 30M |
1/2006 | Incipient | Series D | 24M |
2/2008 | Incipient | Series E | 15.6M |
10/2005 | Ophthonix | Series C | 17M |
11/2009 | Tethys BioScience | Series D | 25M |
3/2006 | Inteliquent | Series C | 12M |
9/2000 | Verticore Technologies | Series B | 5M |
3/2007 | Orqis Medical | Series D | 12M |
6/2016 | Quess Corp | Venture Round | 26.5M |
1/2007 | Standard BioTools | Series E | 0 |
6/2006 | BlueArc | Venture Round | 29M |
2/2019 | Medallia | Series F | 70M |
2/2008 | Ocera Therapeutics | Series C | 0 |
11/2005 | Nanosys | Series C | 0 |
10/2001 | Metro Optix | Series C | 0 |
7/2020 | Frequency Therapeutics | Post-IPO Equity | 42.3M |
7/2020 | Frequency Therapeutics | Post-IPO Equity | 0 |
2/2019 | Medallia | Series F | 0 |
6/2016 | Quess Corp | Venture Round | 0 |
5/2015 | DocuSign | Series F | 0 |
9/2014 | DataStax | Series E | 0 |
11/2009 | Tethys BioScience | Series D | 0 |
2/2008 | Incipient | Series E | 0 |
2/2008 | Ocera Therapeutics | Series C | 0 |
3/2007 | Orqis Medical | Series D | 0 |
1/2007 | Standard BioTools | Series E | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|